Latest Dividend Reinvestment Plans News

Magellan Financial Group reported a 27% drop in statutory net profit but maintained stable operating profit and increased earnings per share by 5%, supported by ongoing share buybacks. The company declared a fully franked interim dividend up 50%, reflecting confidence despite investment performance challenges.

Hansen Technologies has reported a remarkable half-year performance with a 7.3% revenue increase and a staggering 31,000% rise in statutory net profit, underpinned by a strategic acquisition of the Digitalk Group.

Southern Cross Electrical Engineering reports a statutory loss of $12.8 million for H1 2025, impacted by WestConnex dispute costs, yet declares a fully franked interim dividend of 2.5 cents per share.

BCAL Diagnostics reported a slight revenue decline and a persistent net loss in its half-year results, with auditors flagging concerns over its ability to continue without additional funding.

BHP Group Limited has announced a fully franked ordinary dividend of USD 0.73 per share for the half-year ending December 2025, with multiple currency payment options and a Dividend Reinvestment Plan available.

Deterra Royalties Limited has announced a fully franked ordinary dividend of AUD 0.124 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a no-discount option to reinvest.

SRG Global Limited posted a robust half-year result for December 2025, driven by strong segment growth and the acquisition of Total AMS Pty Ltd. The company also raised its interim dividend, signalling confidence in its outlook.

Reliance Worldwide Corporation reported a 4.6% revenue decline and a 34.9% drop in net profit for H1 FY2026, citing US tariffs and weaker demand in key markets. The company balances challenges with cost savings and a shareholder-friendly capital return strategy.

Qualitas Limited reported a robust interim result for the six months to December 2025, with net profit rising 27% and funds under management expanding 18% to $10.9 billion. The company’s focus on real estate private credit and build-to-rent sectors underpinned strong capital deployment and fee growth.

Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.

The GPT Group has reported a remarkable financial turnaround for FY2025, posting a 264% increase in total revenues and declaring a 12 cent distribution per stapled security. This strong performance signals renewed confidence in the property trust’s operational strategy.

ECP Emerging Growth Limited reported a 6.9% portfolio loss for H1 2025, underperforming the ASX Small Ordinaries Index, yet declared a fully franked interim dividend and teased a significant special dividend.